In this study we sought to determine the impact of BRD4 recurrent focal deletions on gene expression, with a particular focus on how BRD4 isoform-level expression is altered in BRD4-amplified ovarian, breast, and endometrial tumors. This evidence concerns the gene BRD4 and endometrium neoplasm.